Cite
MLA Citation
Riccardo Moia et al.. “Anti‐rasburicase antibodies induce clinical refractoriness by inhibiting the enzyme catalytic activity.” Hematological oncology, vol. 38, no. 2, 2020, pp. 204–206. http://access.bl.uk/ark:/81055/vdc_100102565064.0x00004e